Headache, weakness, dizziness, drowsiness, ataxia, dysarthria, insomnia, changes in mood or mental state such as depression and confusion may occur, seizure and peripheral neuropathy may occur after prolonged therapy with high doses of metronidazole.
Temporary moderate leucopenia, thrombocytopenia, skin rashes, urticaria, pruritus may occur occasionally, gynecomastia, erythema multiforme, angioedema and anaphylaxis have been reported rarely.
Other adverse effects include optic neuropathies, urethral discomfort, darkening of urine, elevated liver enzymes, cholestatic hepatitis and jaundice.
View ADR Reporting Link